Novavax unveils phase 3 COVID jab data, but has it missed the boat in US?The top-line phase 3 data for Novavax’ COVID-19 vaccine look good, with a 90% overall efficacy rate, but Share XNovavax unveils phase 3 COVID jab data, but has it missed the boat in US?https://pharmaphorum.com/news/novavax-unveils-phase-3-covid-jab-data-but-has-it-missed-the-boat-in-us/
UK booster trial will test value of third COVID jab doseAll seven COVID-19 vaccines ordered by the UK government will be tested in a new trial that will Share XUK booster trial will test value of third COVID jab dosehttps://pharmaphorum.com/news/uk-booster-trial-will-test-value-of-third-covid-jab-dose/
Novavax delays COVID vaccine filings until Q3Novavax has finally provided some clarity about when its long-awaited COVID-19 vaccine will be ready, saying regulatory filings Share XNovavax delays COVID vaccine filings until Q3https://pharmaphorum.com/news/novavax-delays-covid-vaccine-filings-until-q3-blaming-lack-of-manufacturing-data/
UK Vaccine Taskforce head lifts lid on Novavax dealThe UK’s unique offering as a life sciences research hub helped convince US biotech Novavax to develop its Share XUK Vaccine Taskforce head lifts lid on Novavax dealhttps://pharmaphorum.com/news/novavax-developed-vaccine-in-uk-because-of-rd-opportunities/
World leaders call for international pandemic preparedness treatyMore than 20 world leaders have called for an international treaty for pandemic preparedness to protect the world Share XWorld leaders call for international pandemic preparedness treatyhttps://pharmaphorum.com/news/world-leaders-call-for-international-pandemic-preparedness-treaty/
Novavax confirms efficacy of COVID-19 jab against UK variantA clinical trial has found that Novavax’ COVID-19 vaccine is 86% protective against the UK variant of SARS-CoV-2, Share XNovavax confirms efficacy of COVID-19 jab against UK varianthttps://pharmaphorum.com/news/novavax-confirms-efficacy-of-covid-19-jab-against-uk-variant/
Novavax in talks with FDA over quick approval for COVID-19 shotNovavax hopes its COVID-19 vaccine could be filed in the US in the second quarter, following a potential Share XNovavax in talks with FDA over quick approval for COVID-19 shothttps://pharmaphorum.com/news/novavax-in-talks-with-fda-over-quick-approval-for-covid-19-shot/
Novavax provides 1.1 billion COVID shots to global vaccine driveNovavax has signed a deal to provide 1.1 billion doses of its COVID-19 vaccine to the COVAX global Share XNovavax provides 1.1 billion COVID shots to global vaccine drivehttps://pharmaphorum.com/news/novavax-provides-1-1-billion-covid-shots-to-global-vaccine-drive/
UK reaches 10 million landmark with COVID-19 vaccination programmeThe UK has reached a major landmark with its COVID-19 vaccination programme, with more than 10 million people Share XUK reaches 10 million landmark with COVID-19 vaccination programmehttps://pharmaphorum.com/news/uk-reaches-10-million-landmark-with-covid-19-vaccination-programme/
